The most comprehensive literature review of structural valve deterioration to date just took on this question. Although data were abundant, useful comparisons were few. The authors explain.
The next waves of progress in transcatheter aortic valve replacement are likely to involve expanding indications, valve refinements and new accessory treatments.
Key clinicians from our Aorta Center share guidance on care from referral to medical and surgical management to patient and family follow-up.
When Cleveland Clinic opens a high-tech inpatient hospital in the heart of London in 2021, comprehensive cardiovascular care will be a key focus. Here’s the what, why and how behind this expansion.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Our Heart & Vascular Institute Chair reflects on what’s always new about a top ranking from U.S. News & World Report — and the underlying factors that must remain constant.
Our experts outline their vision of ideal changes to the National Coverage Determination for programs performing transcatheter aortic valve replacement. A CMS decision is due in June 2019.
Despite its malignant prognosis, this connective tissue disorder marked by early aortic dissection is far from unmanageable. One of the largest series reported to date proves the point.
Cleveland Clinic is offering two complimentary dinner symposia on the Friday evening of the ACC meeting in Orlando that can’t be beat for practical clinical value.
Just 1 in 10 aortic valve repair patients required reoperation within a decade, a large study shows. What does this mean for weighing repair as an alternative to replacement for selected patients?
The Inspiris Resilia aortic bioprosthesis is officially launched, and Cleveland Clinic just performed some of its first U.S. commercial implantations. A COMMENCE trial investigator reflects on the device’s points of distinction.